These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7097388)

  • 1. Leukocyte survival in hemodialysis patients.
    Mohr JA; Pederson JA; Long H
    J Okla State Med Assoc; 1982 May; 75(5):114-7. PubMed ID: 7097388
    [No Abstract]   [Full Text] [Related]  

  • 2. [The ECG changes during the performance of hemodialysis using dialysis solution concentrates with different potassium levels in patients with chronic kidney failure and normokalemia].
    Alavi AA; Riabykina GV; Zaruba AIu; Kutsenko AI; Kukharchuk VV; Eliseev AO
    Ter Arkh; 1993; 65(4):58-60. PubMed ID: 8059409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular effects of hemodialysis in chronic kidney disease.
    Prohovnik I; Post J; Uribarri J; Lee H; Sandu O; Langhoff E
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1861-9. PubMed ID: 17406658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hemodialysis on the state of the stomach in chronic renal insufficiency].
    Ryss ES
    Urol Nefrol (Mosk); 1978; (4):48-52. PubMed ID: 684981
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients.
    Knerr K; Füth R; Hemsen P; Mohné W; Heinig A; Kleophas W; Scherbaum WA; Martin S
    Cytokine; 2005 May; 30(3):132-8. PubMed ID: 15826820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis.
    Puskar D; Pasini J; Savić I; Bedalov G; Sonicki Z
    Croat Med J; 2002 Jun; 43(3):306-11. PubMed ID: 12035137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Change in the state of the internal organs in chronic hemodialysis].
    Riabov SI; Spiridonov VN; Stavskaia VV; Ryss ES; Shvaro SV
    Klin Med (Mosk); 1978 Feb; 56(2):76-82. PubMed ID: 633831
    [No Abstract]   [Full Text] [Related]  

  • 9. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease.
    Sela S; Shurtz-Swirski R; Cohen-Mazor M; Mazor R; Chezar J; Shapiro G; Hassan K; Shkolnik G; Geron R; Kristal B
    J Am Soc Nephrol; 2005 Aug; 16(8):2431-8. PubMed ID: 15987755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two different dialysis membranes on leukocyte adhesion and aggregation.
    Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G
    Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of the bone mineral density in hemodialysis patients for different terms].
    Tao L; Xu H; Sun M; Ikeda T
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):177-8. PubMed ID: 11938784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocytosis in a patient on hemodialysis for thirteen years.
    Kaynar K; Dilli UD; Akdogan R; Akdogan E; Ozdemir F; Cobanoglu U; Gul S; Ulusoy S
    Mt Sinai J Med; 2006 Dec; 73(8):1095-7. PubMed ID: 17285202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EEG and ENG findings in patients with chronic renal insufficiency and in hemodialysis patients].
    Sperschneider H; Stein G; Mühlau G; Both R; Fünfstück R; Wieczorek V
    Z Gesamte Inn Med; 1980 Jan; 35(1):25-8. PubMed ID: 7405295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of arterial compliance in patients treated by hemodialysis.
    Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
    Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.
    Flanigan MJ
    Semin Dial; 2008; 21(3):226-9. PubMed ID: 18363598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Muscular blood flow in patients with chronic renal insufficiency on periodic dialysis].
    Scarpelli PT; Fantini F; Viola S; Rizzo M; Sodi A
    Minerva Nefrol; 1972; 19(4):261-4. PubMed ID: 4681102
    [No Abstract]   [Full Text] [Related]  

  • 18. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS).
    Bragg-Gresham JL; Fissell RB; Mason NA; Bailie GR; Gillespie BW; Wizemann V; Cruz JM; Akiba T; Kurokawa K; Ramirez S; Young EW
    Am J Kidney Dis; 2007 Mar; 49(3):426-31. PubMed ID: 17336704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should dialysis fluid be individualized for the chronic hemodialysis patient? Temperature.
    Selby NM; McIntyre CW
    Semin Dial; 2008; 21(3):229-31. PubMed ID: 18363597
    [No Abstract]   [Full Text] [Related]  

  • 20. The silent period in patients with chronic renal failure undergoing hemodialysis.
    Resende LA; Caramori JC; Kimaid PA; Martin LC; Barretti P
    Electromyogr Clin Neurophysiol; 2002; 42(5):275-9. PubMed ID: 12168248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.